Haisco Pharmaceutical (SHE:002653) will provide up to 261 million yuan in loans to its holding subsidiary Haisijinuo for research and development and working capital.
The five-year facility carries a 3.05% annual interest rate, with minority shareholder Hailikesi contributing 30 million yuan on pro rata terms, according to a Friday filing with the Shenzhen bourse.
Shares of the pharmaceutical company rose nearly 4% in recent trade.